Centro Einstein-Rockefeller-CUNY para la investigación del SIDA
Descripción general
The Einstein-Rockefeller-CUNY Center for AIDS Research (ERC-CFAR) synergizes the expertise of over 150 outstanding basic, clinical, translational, behavioral, implementation, and public health investigators from three major academic institutions at the forefront of HIV/AIDS research: Albert Einstein College of Medicine (Einstein), Rockefeller University (Rockefeller), and City University of New York (CUNY). Our scientific affinity for and long-standing commitment to HIV/AIDS research are consequences of our New York City location, which was one of the first epicenters of the HIV pandemic almost 40 years ago. There are over 128,000 people with HIV (PWH) in NYC, the highest number in any city in the country, and the site of four of the 48 counties with the highest number of new HIV diagnoses targeted by the United States federal government Ending the HIV Epidemic in the U.S. (EHE) plan.
AIDS research at the ERC-CFAR is structured around four interdisciplinary research programs
Reducir la incidencia del VIH
Investigación hacia la cura del VIH
Desarrollar terapias contra el VIH de próxima generación
Comorbidities, Coinfections, and Complications
ERC-CFAR at a Glance
Our Einstein-Rockefeller-CUNY Center for AIDS research (ERC-CFAR) is one of 18 Centers for AIDS Research (CFAR) funded by the NIH.
-
$44.5M
NIH OAR Funding*
-
160
Investigators
-
>1,250
HIV/AIDS-related published papers*
-
5
Research and Operational Cores
-
>6,200
PWH in active care in our Clinical Cohort Database
Gift Opportunities
We need your help to end the HIV epidemic by supporting our efforts to develop highly innovative new treatments to cure HIV infection, treat HIV infection and prevent HIV infection. To make a donation, please contact us at 718-430-2740 or einstein-erc-cfar@einsteinmed.org.
Volunteer for Clinical Studies
With the help of research volunteers, ERC-CFAR investigators are testing new therapies to prevent, treat or cure HIV infection. For more information about ongoing clinical trials please click here.
